Amy McKee

Amy McKee is an accomplished professional with extensive experience in regulatory consulting and oncology. Currently serving as Senior Vice President at AstraZeneca since September 2024, Amy previously held leadership roles at Parexel, including Senior Vice President and Chief Medical Officer, as well as Vice President of Regulatory Consulting Services. Amy's tenure at BioCryst Pharmaceuticals includes the position of Director starting in September 2021. Earlier career experiences include roles at the FDA as Clinical Team Leader and various leadership positions within the Oncology Center of Excellence. Academic credentials include a Pediatric Hematology/Oncology Fellowship from The Johns Hopkins University School of Medicine, an M.D. from Tulane University, and a B.A. from Middlebury College.